BioArctic AB (BRCTF)
35.00
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
BioArctic Total Assets (Quarterly) : 281.25M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 281.25M |
| December 31, 2025 | 279.35M |
| September 30, 2025 | 276.56M |
| June 30, 2025 | 244.45M |
| March 31, 2025 | 211.36M |
| December 31, 2024 | 100.61M |
| September 30, 2024 | 107.83M |
| June 30, 2024 | 106.89M |
| March 31, 2024 | 106.27M |
| December 31, 2023 | 117.69M |
| September 30, 2023 | 114.34M |
| June 30, 2023 | 100.60M |
| March 31, 2023 | 111.38M |
| December 31, 2022 | 82.38M |
| September 30, 2022 | 81.60M |
| June 30, 2022 | 77.54M |
| March 31, 2022 | 90.86M |
| December 31, 2021 | 99.15M |
| September 30, 2021 | 106.90M |
| June 30, 2021 | 113.83M |
| Date | Value |
|---|---|
| March 31, 2021 | 115.42M |
| December 31, 2020 | 127.89M |
| September 30, 2020 | 120.23M |
| June 30, 2020 | 118.05M |
| March 31, 2020 | 115.32M |
| December 31, 2019 | 126.41M |
| September 30, 2019 | 126.08M |
| June 30, 2019 | 137.45M |
| March 31, 2019 | 141.71M |
| December 31, 2018 | 157.12M |
| September 30, 2018 | 116.07M |
| June 30, 2018 | 118.91M |
| March 31, 2018 | 132.38M |
| December 31, 2017 | 139.30M |
| September 30, 2017 | 74.85M |
| June 30, 2017 | 75.74M |
| March 31, 2017 | |
| December 31, 2016 | 77.93M |
| September 30, 2016 | 12.12M |
| June 30, 2016 | 13.20M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Hansa Biopharma AB | 122.00M |
| Swedish Orphan Biovitrum AB | 8.530B |
| Diamyd Medical AB | 28.11M |
| BONESUPPORT HOLDING AB | 117.45M |
| BioInvent International AB | 56.16M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 50.51M |
| Shareholders Equity (Quarterly) | 230.74M |
| Debt to Equity Ratio | 0.0185 |
| Current Ratio | 6.538 |
| Net Debt Paydown Yield | 0.00% |